Who Owns APVO?

Aptevo Therapeutics Inc. — Institutional Ownership & 13F Holdings

$4.96

+0.04 (+0.81%)

Market Cap

$10.8M

Shares Outstanding

1,181,720

Institutional Holders

8

Total Inst. Value

$3.2B

% of Float Held

QoQ Holder Change

-3

Institutional data as of Q1 2025

New Positions

2

Closed Positions

7

Increased

3

Decreased

2

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1CLEAR STREET LLCNew$3.2B2,800
2GEODE CAPITAL MANAGEMENT, LLCNew$12K10,526
3Tower Research Capital LLC (TRC)$4K3,255
4BANK OF AMERICA CORP /DE/$2K2,318
5SBI Securities Co., Ltd.$813701
6BlackRock, Inc.$2824
7OSAIC HOLDINGS, INC.$11
8MORGAN STANLEY$04

Biggest Buyers & Sellers This Quarter

Top Sellers

FundShares RemovedValue
MORGAN STANLEY-4K$0
OSAIC HOLDINGS, INC.-44$1

Related Stocks

Frequently Asked Questions

How many institutional investors hold APVO?

As of Q1 2025, 8 institutional investors report holding APVO (Aptevo Therapeutics Inc.) in their 13F filings.

Which hedge fund owns the most APVO?

The largest institutional holder of APVO is CLEAR STREET LLC with $3.2B in shares.

Are institutions buying or selling APVO?

This quarter, 2 institutions opened new positions in APVO and 7 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.